Squamous cell carcinoma future and investigational treatment strategies: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Squamous cell carcinoma}} {{CMG}}; '''Associate Editor(s)-in-Chief:''' Aditya Govindavarjhulla, M.B.B.S. [mailto:agovi@perfuse.org],[[User:R...")
 
 
(3 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{Squamous cell carcinoma}}
#redirect:[[Squamous cell carcinoma future or investigational therapies]]
{{CMG}}; '''Associate Editor(s)-in-Chief:''' [[User:Aditya Govindavarjhulla|Aditya Govindavarjhulla, M.B.B.S.]] [mailto:agovi@perfuse.org],[[User:Raviteja Reddy Guddeti|Raviteja Guddeti, M.B.B.S.]] [mailto:rgudetti@perfuse.org]
 
== Future and Investigational treatment strategies ==
In 2007, Australian biopharmaceutical company Clinuvel Pharmaceuticals Limited began [[clinical trials]] with a [[melanocyte-stimulating hormone]] called [[melanotan]]  (known by the [[International Nonproprietary Name]] ''afamelanotide'', formerly CUV1647)<ref name="Clinuvel-INN">{{Cite web|url=http://www.clinuvel.com/resources/pdf/asx_announcements/2008/20080617WHOGenericName.pdf|title=World Health Organisation assigns CUV1647 generic name|accessdate=2008-06-17|publisher=Clinuvel|year=2008|format=[[Portable Document Format|PDF]]}}</ref> to provide [[photoprotection]] for organ transplant patients against squamous cell carcinoma of the skin and [[actinic keratosis]].<ref name="Clinuvel">[http://www.clinuvel.com/en/faqs/ Clinuvel » Investors » FAQs<!-- Bot generated title -->]</ref><ref name="PharmaAsia">[http://www.pharmaasia.com/article-6618-clinuvelsdrugbeginsglobalphaseiiskincancertrials-Asia.html PharmaAsia - Clinuvel’s Drug Begins Global Phase II Skin Cancer Trials]</ref>
 
[[Cetuximab]] a monoclonal antibody that targets the epidermal growth factor receptor (EGFR), has antitumor activity in patients with advanced squamous cell carcinoma of the skin, as initially suggested by case reports.
 
Use of natural agents in cancer therapy is increasing. For oral squamous cell carcinoma , use of curcumin microemulsions is under considerations. New modalities like use of ultra sound mediated delivery of these microemulsions. <ref name="pmid3289448">{{cite journal|author=Lenaz G, Fato R, Baracca A, Solaini G, Parenti Castelli G, Rabbi A |title=Dynamics of biological membranes |journal=Ann. Ist. Super. Sanita |volume=24 |issue=1 |pages=9–21 |year=1988 |pmid=3289448 |doi= |url=}}</ref>
 
==References==
 
{{reflist|2}}
 
[[Category:Dermatology]]
[[Category:Types of cancer]]
[[Category:Oncology]]
[[Category:Otolaryngology]]
[[Category:Mature chapter]]
[[Category:Grammar]]
 
[[de:Plattenepithelkarzinom]]
[[he:קרצינומת תאי קשקש]]
[[nl:Plaveiselcelcarcinoom]]
[[pl:Rak kolczystokomórkowy skóry]]
[[tr:Skuamöz hücreli karsinoma]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 15:31, 28 August 2012